283 related articles for article (PubMed ID: 19958640)
1. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
[TBL] [Abstract][Full Text] [Related]
2. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
3. Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance.
Vinayagamoorthi R; Bobby Z; Sridhar MG
J Endocrinol; 2008 May; 197(2):287-96. PubMed ID: 18434358
[TBL] [Abstract][Full Text] [Related]
4. [The expression of insulin signal transduction molecules and islet alpha cell insulin resistance].
Du RQ; Li HL; Yang WY; Xiao JZ; Lou DJ; Wang B; Bai XP; Pan L
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2542-6. PubMed ID: 17198562
[TBL] [Abstract][Full Text] [Related]
5. [Research of the relationship between insulin signal transduction and glucose transportation in rats after trauma].
Jiang Y; Wu GH
Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):214-7. PubMed ID: 19563078
[TBL] [Abstract][Full Text] [Related]
6. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
Duan XY; Zhao HP; Fan JG
J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835
[TBL] [Abstract][Full Text] [Related]
7. [Role of c-Jun NH (2)-terminal kinase in insulin resistance after burn].
Chen XL; Xia ZF; Wei D; Ben DF; Tang HT; Ge SD
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):62-4. PubMed ID: 17403295
[TBL] [Abstract][Full Text] [Related]
8. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis].
Zhang H; Feng Q; Li HS; Chen SD; Wang XN; Peng JH; Zhang N; Hu YY
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):928-33. PubMed ID: 18782536
[TBL] [Abstract][Full Text] [Related]
10. [Establishing a rat insulin-resistant fatty liver model].
Chen SQ; Liu Q; Sun H; Zhang GL; Shi XF
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):105-8. PubMed ID: 15727695
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):973-83. PubMed ID: 19307976
[TBL] [Abstract][Full Text] [Related]
12. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
[TBL] [Abstract][Full Text] [Related]
13. Low salt intake modulates insulin signaling, JNK activity and IRS-1ser307 phosphorylation in rat tissues.
Prada PO; Coelho MS; Zecchin HG; Dolnikoff MS; Gasparetti AL; Furukawa LN; Saad MJ; Heimann JC
J Endocrinol; 2005 Jun; 185(3):429-37. PubMed ID: 15930169
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
15. Taurine prevents free fatty acid-induced hepatic insulin resistance in association with inhibiting JNK1 activation and improving insulin signaling in vivo.
Wu N; Lu Y; He B; Zhang Y; Lin J; Zhao S; Zhang W; Li Y; Han P
Diabetes Res Clin Pract; 2010 Dec; 90(3):288-96. PubMed ID: 20855122
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
17. [Study on therapeutic effects of metformin on rat fatty livers induced by high fat feeding].
Gao ZQ; Lu FE; Dong H; Xu LJ; Wang KF; Zhou X
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):101-4. PubMed ID: 15727694
[TBL] [Abstract][Full Text] [Related]
18. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
[TBL] [Abstract][Full Text] [Related]
20. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
